Mark Elliott Boulding - Feb 1, 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Exec. VP and CLO
Signature
/s/ Avraham S. Adler, attorney-in-fact
Stock symbol
PTCT
Transactions as of
Feb 1, 2022
Transactions value $
-$31,162
Form type
4
Date filed
2/3/2022, 03:57 PM
Previous filing
Jan 11, 2022
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$31.2K -779 -1.26% $40.00 61.1K Feb 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,550 RSUs from a January 29, 2020 grant of 10,200 RSUs.